Tuberculosis and HIV co-infection.
Andrzej Pawlowski,Marianne Jansson,Marianne Jansson,Markus Sköld,Martin E. Rottenberg,Gunilla Källenius +5 more
TLDR
This review highlights immunological events that may accelerate the development of one of the two diseases in the presence of the co-infecting organism and describes gaps in knowledge and needs for future studies to develop preventive measures against theTwo diseases.Abstract:
Tuberculosis (TB) and HIV co-infections place an immense burden on health care systems and pose particular diagnostic and therapeutic challenges. Infection with HIV is the most powerful known risk factor predisposing for Mycobacterium tuberculosis infection and progression to active disease, which increases the risk of latent TB reactivation 20-fold. TB is also the most common cause of AIDS-related death. Thus, M. tuberculosis and HIV act in synergy, accelerating the decline of immunological functions and leading to subsequent death if untreated. The mechanisms behind the breakdown of the immune defense of the co-infected individual are not well known. The aim of this review is to highlight immunological events that may accelerate the development of one of the two diseases in the presence of the co-infecting organism. We also review possible animal models for studies of the interaction of the two pathogens, and describe gaps in knowledge and needs for future studies to develop preventive measures against the two diseases.read more
Citations
More filters
Journal ArticleDOI
Syndemics and the biosocial conception of health
TL;DR: The contributions of the syndemics approach for understanding both interacting chronic diseases in social context, and the implications of a Syndemics orientation to the issue of health rights, are examined.
Journal ArticleDOI
Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing
Yanjia J. Zhang,Manchi C. M. Reddy,Thomas R. Ioerger,Alissa C. Rothchild,Véronique Dartois,Brian M. Schuster,Andrej Trauner,Deeann Wallis,Stacy Galaviz,Curtis Huttenhower,James C. Sacchettini,Samuel M. Behar,Eric J. Rubin +12 more
TL;DR: A genome-scale study of Mycobacterium tuberculosis is presented that uncovers the bacterial determinants of surviving host immunity, sets of genes the authors term "counteractomes", and identifies a small-molecule inhibitor of Mtb tryptophan synthesis, which converts Mtb into a tryPTophan auxotroph and restores the efficacy of a failed host defense.
Journal ArticleDOI
Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells
Shunsuke Sakai,Keith D. Kauffman,Jason M. Schenkel,Cortez McBerry,Katrin D. Mayer-Barber,David Masopust,Daniel L. Barber +6 more
TL;DR: It is shown that control of M. tuberculosis correlates with the ability of CD4 T cells to efficiently enter the lung parenchyma rather than produce high levels of IFN-γ.
Journal ArticleDOI
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Michael J. A. Reid,Nimalan Arinaminpathy,Amy Bloom,Barry R. Bloom,Catharina Boehme,Richard E. Chaisson,Daniel P. Chin,Gavin J. Churchyard,Helen Cox,Lucica Ditiu,Mark Dybul,Jeremy Farrar,Anthony S. Fauci,Endalkachew Fekadu,Paula I Fujiwara,Timothy B. Hallett,Christy L Hanson,Mark Harrington,Nick Herbert,Philip C. Hopewell,Chieko Ikeda,Dean T. Jamison,Aamir J. Khan,Irene Koek,Nalini Krishnan,Aaron Motsoaledi,Madhukar Pai,Mario C. Raviglione,Mario C. Raviglione,Almaz Sharman,Small Pm,Soumya Swaminathan,Zelalem Temesgen,Anna Vassall,Anna Vassall,Nandita. Venkatesan,Kitty van Weezenbeek,Gavin Yamey,Bruce D. Agins,Sofia Alexandru,Jason R. Andrews,Naomi Beyeler,Stela Bivol,Grania Brigden,Adithya Cattamanchi,Danielle Cazabon,Valeriu Crudu,Amrita Daftary,Puneet Dewan,Laurie K Doepel,Robert W Eisinger,Victoria Y. Fan,Victoria Y. Fan,Sara Fewer,Jennifer Furin,Jeremy D. Goldhaber-Fiebert,Gabriela B. Gomez,Stephen M. Graham,Stephen M. Graham,Stephen M. Graham,Devesh Gupta,Maureen Kamene,Sunil D. Khaparde,Eunice W Mailu,Enos Masini,Lorrie McHugh,Ellen M. H. Mitchell,Suerie Moon,Suerie Moon,Michael Osberg,Tripti Pande,Lea Prince,Kirankumar Rade,Raghuram Rao,Michelle Remme,James A Seddon,James A Seddon,Casey Selwyn,Priya B. Shete,Kuldeep Singh Sachdeva,Guy Stallworthy,Juan F. Vesga,Valentina Vilc,Eric Goosby +83 more
TL;DR: The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation, which answer the question of how countries with high-burden tuberculosis and their development partners should target their future investments.
Journal ArticleDOI
Tuberculosis and HIV Coinfection
TL;DR: The clinical management of HIV-associated TB includes the integration of effective anti-TB treatment, use of concurrent antiretroviral therapy (ART), prevention of HIV -related comorbidities, management of drug cytotoxicity, and prevention/treatment of immune reconstitution inflammatory syndrome (IRIS).
References
More filters
Journal ArticleDOI
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley,David Price,Timothy W. Schacker,Tedi E. Asher,Guido Silvestri,Srinivas S. Rao,Zachary Kazzaz,Ethan Bornstein,Olivier Lambotte,Daniel M. Altmann,Bruce R. Blazar,Benigno Rodriguez,Leia Teixeira-Johnson,Alan L. Landay,Jeffrey N. Martin,Frederick Hecht,Louis J. Picker,Michael M. Lederman,Steven G. Deeks,Daniel C. Douek +19 more
TL;DR: It is shown that increased lipopolysaccharide is bioactive in vivo and correlates with measures of innate and adaptive immune activation, which establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection.
Journal ArticleDOI
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
TL;DR: The global burden of tuberculosis remains enormous, mainly because of poor control in Southeast Asia, sub-Saharan Africa, and eastern Europe, and because of high rates of M tuberculosis and HIV coinfection in some African countries.
Journal ArticleDOI
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
Elizabeth L. Corbett,Catherine J. Watt,Neff Walker,Dermot Maher,Brian G. Williams,Mario C. Raviglione,Christopher Dye +6 more
TL;DR: The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency.
Journal ArticleDOI
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day,Daniel Kaufmann,Photini Kiepiela,Julia A. Brown,Eshia Moodley,Sharon Reddy,Elizabeth W Mackey,Joseph D. Miller,Alasdair Leslie,Chantal DePierres,Zenele Mncube,Jaikumar Duraiswamy,Baogong Zhu,Quentin Eichbaum,Marcus Altfeld,E. John Wherry,Hoosen M. Coovadia,Philip J. R. Goulder,Philip J. R. Goulder,Philip J. R. Goulder,Paul Klenerman,Rafi Ahmed,Gordon J. Freeman,Bruce D. Walker,Bruce D. Walker,Bruce D. Walker +25 more
TL;DR: The data indicate that the immunoregulatory PD-1/PD-L1 pathway is operative during a persistent viral infection in humans, and define a reversible defect in HIV-specific T-cell function.
Journal ArticleDOI
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Teunis B.H. Geijtenbeek,Douglas S. Kwon,Ruurd Torensma,S.J. van Vliet,G.C.F. van Duijnhoven,J. Middel,I.L.M.H.A. Cornelissen,H.S.L.M. Nottet,Vineet N. KewalRamani,Dan R. Littman,Carl G. Figdor,Y. van Kooyk +11 more
TL;DR: It is proposed that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.